Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non Operating Investment Income: 2011-2018

Historic Non Operating Investment Income for EyePoint Pharmaceuticals (EYPT) over the last 5 years, with Jun 2018 value amounting to -$26.3 million.

  • EyePoint Pharmaceuticals' Non Operating Investment Income was N/A to -$18.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$44.0 million, marking a year-over-year change of. This contributed to the annual value of -$26.3 million for FY2018, which is N/A change from last year.
  • According to the latest figures from FY2018, EyePoint Pharmaceuticals' Non Operating Investment Income is -$26.3 million, which was down 656,850.00% from -$4,000 recorded in FY2015.
  • EyePoint Pharmaceuticals' 5-year Non Operating Investment Income high stood at -$4,000 for FY2015, and its period low was -$26.3 million during FY2018.
  • For the 1-year period, EyePoint Pharmaceuticals' Non Operating Investment Income averaged around -$26.3 million, with its median value being -$26.3 million (2018).